Literature DB >> 16919575

Overestimation of postischemic myocardial stunning on gated SPECT imaging: correlation with echocardiography.

R Parker Ward1, Ethan L Gundeck, Roberto M Lang, Kirk T Spencer, Kim A Williams.   

Abstract

BACKGROUND: Postischemic global and regional left ventricular (LV) dysfunction on stress-gated single photon emission computed tomography (SPECT) imaging is attributed widely to myocardial stunning. We sought to determine the specificity of gated SPECT for the detection of myocardial stunning after ischemic stress. METHODS AND
RESULTS: Twenty-seven patients with an ischemic response to stress on dual-isotope exercise SPECT were enrolled prospectively. Transthoracic echocardiography was performed just before stress gated SPECT for assessment of regional wall motion and quantitative LV ejection fraction (LVEF). The 17 myocardial segments for each patient were scored for myocardial perfusion by stress gated SPECT, and regional wall motion by stress gated SPECT and echo. Of the 459 myocardial segments, 41% had perfusion defects, 15% had stress gated SPECT regional wall motion abnormality, 4.8% had poststress echo regional wall motion abnormality, and 3.9% had baseline regional wall motion abnormality. Overall, a stress gated SPECT regional wall motion abnormality had a sensitivity of 100% and a specificity of 89%. Among reversible perfusion defects of moderate severity or more, a stress gated SPECT regional wall motion abnormality had a specificity of 41% and a positive predictive value of 8%. Stress gated SPECT LVEF was similar to poststress echo LVEF for all patients, but significantly lower in patients with reversible perfusion defects of moderate severity or more.
CONCLUSION: Post-stress gated SPECT imaging overestimates global and regional myocardial stunning. Caution should be exercised in interpreting poststress global or regional LV function on stress gated SPECT in scans with reversible ischemia.

Entities:  

Mesh:

Year:  2006        PMID: 16919575     DOI: 10.1016/j.nuclcard.2006.03.009

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  31 in total

Review 1.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

2.  Incremental value of assessment of regional wall motion for detection of multivessel coronary artery disease in exercise (201)Tl gated myocardial perfusion imaging.

Authors:  Naoya Shirai; Hiroyuki Yamagishi; Minoru Yoshiyama; Masakazu Teragaki; Kaname Akioka; Kazuhide Takeuchi; Junichi Yoshikawa; Hironobu Ochi
Journal:  J Nucl Med       Date:  2002-04       Impact factor: 10.057

3.  Gated single-photon emission tomography imaging protocol to evaluate myocardial stunning after exercise.

Authors:  J Hashimoto; A Kubo; R Iwasaki; S Iwanaga; H Mitamura; S Ogawa; S Kosuda
Journal:  Eur J Nucl Med       Date:  1999-12

4.  Two-dimensional echocardiographic determination of left ventricular volume, systolic function, and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography.

Authors:  N B Schiller
Journal:  Circulation       Date:  1991-09       Impact factor: 29.690

5.  Prolonged impairment of regional contractile function after resolution of exercise-induced angina. Evidence of myocardial stunning in patients with coronary artery disease.

Authors:  G Ambrosio; S Betocchi; L Pace; M A Losi; P Perrone-Filardi; A Soricelli; F Piscione; J Taube; F Squame; M Salvatore; J L Weiss; M Chiariello
Journal:  Circulation       Date:  1996-11-15       Impact factor: 29.690

6.  Can the reversible regional wall motion abnormalities on stress gated Tc-99m sestamibi SPECT predict a future cardiac event?

Authors:  Nunzia Rosa Petix; Stelvio Sestini; Gabriella Marcucci; Angela Coppola; Angela Arena; Franco Nassi; Andrea Taiti; Vincenzo Guarnaccia; Alberto Mennuti; Vincenzo Mazzoni
Journal:  J Nucl Cardiol       Date:  2005 Jan-Feb       Impact factor: 5.952

7.  Prolonged left ventricular dysfunction occurs in patients with coronary artery disease after both dobutamine and exercise induced myocardial ischaemia.

Authors:  E Barnes; C S Baker; D P Dutka; O Rimoldi; C A Rinaldi; P Nihoyannopoulos; P G Camici; R J Hall
Journal:  Heart       Date:  2000-03       Impact factor: 5.994

8.  Persistence of regional left ventricular dysfunction after exercise-induced myocardial ischemia.

Authors:  D C Homans; E Sublett; X Z Dai; R J Bache
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

9.  Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina.

Authors:  P Camici; L I Araujo; T Spinks; A A Lammertsma; J C Kaski; M J Shea; A P Selwyn; T Jones; A Maseri
Journal:  Circulation       Date:  1986-07       Impact factor: 29.690

10.  Improvement of resting myocardial asynergy with cessation of upright bicycle exercise.

Authors:  A Rozanski; U Elkayam; D S Berman; G A Diamond; J Prause; H J Swan
Journal:  Circulation       Date:  1983-03       Impact factor: 29.690

View more
  9 in total

1.  Positron emission tomography for perfusion and function.

Authors:  Kim A Williams
Journal:  Curr Cardiol Rep       Date:  2008-02       Impact factor: 2.931

2.  Deciding wisely: A case for an effective use of myocardial perfusion imaging.

Authors:  Rami Doukky
Journal:  J Nucl Cardiol       Date:  2017-11-29       Impact factor: 5.952

3.  The significance of post-stress decrease in left ventricular ejection fraction in patients undergoing regadenoson stress gated SPECT myocardial perfusion imaging.

Authors:  Javier Gomez; Yasmeen Golzar; Ibtihaj Fughhi; Adebayo Olusanya; Rami Doukky
Journal:  J Nucl Cardiol       Date:  2017-02-08       Impact factor: 5.952

4.  Left ventricular mechanical dyssynchrony for CAD diagnosis: Does it have incremental clinical values?

Authors:  Zhixin Jiang; Weihua Zhou
Journal:  J Nucl Cardiol       Date:  2018-09-14       Impact factor: 5.952

5.  Effect of patient positioning on the evaluation of myocardial perfusion SPECT.

Authors:  Bertalan Kracskó; Sándor Barna; Orsolya Sántha; Anett Kiss; József Varga; Attila Forgács; Ildikó Garai
Journal:  J Nucl Cardiol       Date:  2017-03-30       Impact factor: 5.952

Review 6.  Does myocardial perfusion imaging provide incremental prognostic information to left ventricular ejection fraction?

Authors:  Daniel W Mudrick; Eric Velazquez; Salvador Borges-Neto
Journal:  Curr Cardiol Rep       Date:  2010-03       Impact factor: 2.931

7.  Myocardial imaging with 99mTc-Tetrofosmin: Influence of post-stress acquisition time, regional radiotracer uptake, and wall motion abnormalities on the clinical result.

Authors:  Assuero Giorgetti; Annette Kusch; Mirta Casagranda; Irene D'Aragona Tagliavia; Paolo Marzullo
Journal:  J Nucl Cardiol       Date:  2009-12-15       Impact factor: 5.952

8.  Comparative assessment of rest and post-stress left ventricular volumes and left ventricular ejection fraction on gated myocardial perfusion imaging (MPI) and echocardiography in patients with transient ischaemic dilation on adenosine MPI: myocardial stunning or subendocardial hypoperfusion?

Authors:  Louise Emmett; Austin Ng; Leo Ha; Robert Russo; Robert Mansberg; Wei Zhao; S Vincent Chow; Leonard Kritharides
Journal:  J Nucl Cardiol       Date:  2012-05-08       Impact factor: 5.952

9.  Tetrofosmin early time gated post-stress single-photon emission computed tomography imaging: feasibility and potential benefits.

Authors:  Laurent Philippe; Bertrand Mérino; Tanguy Blaire; Alban Bailliez; Danielle Casset-Senon; Maurice Levy; Arnaud Halley; Guillaume Divry
Journal:  J Nucl Cardiol       Date:  2010-11-11       Impact factor: 5.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.